Caption Management, LLC Eli Lilly & CO Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $6.14 Million - $7.24 Million	11,700 New	11,700 $6.82 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $70,265 - $80,075	237 New	237 $77,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $2.17 Million - $2.8 Million	-12,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $1.97 Million - $2.55 Million	12,000 New	12,000 $2.24 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $757,000 - $868,800	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $742,099 - $876,000	10,000 New	10,000 $773,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.